Skip to main content

Highlights

  1. 1
    eLife · 2024
    PMID: 39259576PMCID: PMC11390108DOISenior author4 citations
  2. 2
    Science advances · 2025
    PMID: 41202131PMCID: PMC12594195DOISenior author

Publications

44 publications

Active

1 grant
  • PI
    To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models
    National Cancer Institute · 2020–2026
    R01CA244413-05
Completed grants (7)
  • PI
    Addgene 693625
    Addgene, Inc. · 2022–2023
    Addgene 693625
  • PI
    Targeting the Epithelial to Mesenchymal Transition-Related Chemoresistance in Breast Cancer
    National Cancer Institute · 2016–2021
    R01CA205418-05
  • KP
    Modeling Tumor-Stroma Crosstalk in Lung Cancer to Identify Targets for Therapy
    National Cancer Institute · 2015–2020 · via Methodist Hospital Research Institute
    U01CA188388-04
  • KP
    Center for Systematic Modeling of Cancer Development
    National Cancer Institute · 2014–2016 · via Methodist Hospital Research Institute
    U54CA149196-05 EW
  • KP
    Molecular Mechanisms of Tumor-Initiated Premetastatic Niche Formation in Lung Stroma
    National Cancer Institute · 2010–2015
    R01CA135417-01A2
  • KP
    Center on the Microenvironment and Metastasis
    National Cancer Institute · 2009–2015 · via Cornell University - Ithaca
    U54CA143876-05 EW
  • KP
    Microfluidic Tumor Models to Analyze the Role of Physiochemical Cues in the Agniogenic Switch
    National Cancer Institute · 2009–2011 · via Cornell University - Ithaca
    RC1CA146065-02EWO

News mentions

  • Scientists Find a New Way to Reverse Immune Suppression in Tumors
    September 20, 2021

    Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new way to counter this immunosuppressive effect.